Dongxuan Ni

Discovery of betulinaldehyde as a natural RORγt agonist

Feng Yang, Ruihan Zhang, Dongxuan Ni et al. · Fitoterapia · 2019 · 25 citations

Pharmacy, Medicinal Chemistry, Pharmacology +4

An ATG4B inhibitor blocks autophagy and sensitizes Sorafenib inhibition activities in HCC tumor cells

Yanqiu Xie, Shijie Fan, Dongxuan Ni et al. · Bioorganic & Medicinal Chemistry · 2023 · 15 citations · Full text

Life Sciences, Cancer Biology, Oncology +16

Spiroarborin, an <i>ent</i>-Clerodane Homodimer from <i>Callicarpa arborea</i> as an Inhibitor of the Eleven-Nineteen Leukemia (ENL) Protein by Targeting the YEATS Domain

De-Bing Pu, Siqi Guo, Dongxuan Ni et al. · Journal of Natural Products · 2022 · 13 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +10

Synthesis and anti-proliferative activity evaluation of novel 1,4-naphthoquinones possessing pyrido[2,3-d]pyrimidine scaffolds

Chong Zhang, Guangfei Sun, Qiujv Peng et al. · RSC Advances · 2016 · 12 citations

Pharmacy, Medicinal Chemistry, Pharmacology +11

Design, synthesis and anti-HIV evaluation of 5-alkyl- 6-(benzo[d][1,3]dioxol-5-alkyl)-2-mercaptopyrimidin-4(3H)-ones as potent HIV-1 NNRTIs

Yiming Li, Rong‐Hua Luo, Liu‐Meng Yang et al. · Bioorganic Chemistry · 2020 · 12 citations

Pharmacy, Medicinal Chemistry, Pharmacology +14